PLx Pharma Inc. Common Stock
PLXP
PLXP was delisted on the 12th of April, 2023.
18 hedge funds and large institutions have $6.52M invested in PLx Pharma Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 18 → 18 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0.34% less ownership
Funds ownership: 22.32% → 21.98% (-0.34%)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
99% less capital inflows, than outflows
Capital inflows: $946 | Capital outflows: $79.1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PIMG
Patriot Investment Management Group
Knoxville,
Tennessee
|
+$604 |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$160 |
| 3 |
Tower Research Capital (TRC)
New York
|
+$106 |
| 4 |
Private Advisor Group
Morristown,
New Jersey
|
+$76 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
-$25K |
| 2 |
FM
Fondren Management
Houston,
Texas
|
-$23K |
| 3 |
BlackRock
New York
|
-$21.7K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$3K |
| 5 |
Millennium Management
New York
|
-$2.75K |
PLXP Hedge Fund Activity: Q2 2020 in Review
18 of the 4,890 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q2 2020, worth a combined $6.52M — up 42% from $4.6M a quarter earlier.
Fund positioning in PLXP was balanced in Q2 2020: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 4 trimmed.
The largest buyer was Patriot Investment Management Group, opening a new position worth an estimated $604. The largest seller was Northern Trust, exiting entirely with an estimated $25K sold.
- 18 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q2 2020, unchanged from Q1 2020.
- Funds reported $6.52M of PLx Pharma Inc. Common Stock stock for Q2 2020, up 42% quarter-over-quarter.
- 3 funds opened new PLx Pharma Inc. Common Stock positions in Q2 2020 and 3 closed out, a net change of 0 holders.
- The largest PLx Pharma Inc. Common Stock buyer in Q2 2020 was Patriot Investment Management Group, an estimated $604 added.
- The largest PLx Pharma Inc. Common Stock seller in Q2 2020 was Northern Trust, an estimated $25K sold.
Based on aggregated 13F filings for Q2 2020.